$1.48
-0.03[-1.99%]
Last update: 9:23AM Get Real Time Here
Cocrystal Pharma
(NASDAQ:COCP)Cocrystal Pharma Stock (NASDAQ:COCP), Analyst Ratings, Price Targets, Predictions
Cocrystal Pharma Inc has a consensus price target of $10, established from looking at the 11 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on April 4, 2024, March 20, 2024, and January 3, 2024. With an average price target of $10 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 575.68% upside for Cocrystal Pharma Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Cocrystal Pharma
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/04/2024 | COCP | Buy Now | Cocrystal Pharma | $1.48 | 575.68% | HC Wainwright & Co. | Raghuram Selvaraju | → $10 | Reiterates | Buy → Buy | Get Alert |
| 03/20/2024 | COCP | Buy Now | Cocrystal Pharma | $1.48 | 575.68% | HC Wainwright & Co. | Raghuram Selvaraju | → $10 | Reiterates | Buy → Buy | Get Alert |
| 01/03/2024 | COCP | Buy Now | Cocrystal Pharma | $1.48 | 575.68% | HC Wainwright & Co. | Raghuram Selvaraju | $12 → $10 | Maintains | Buy | Get Alert |
| 12/04/2023 | COCP | Buy Now | Cocrystal Pharma | $1.48 | 710.81% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
| 10/04/2023 | COCP | Buy Now | Cocrystal Pharma | $1.48 | 710.81% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2023 | COCP | Buy Now | Cocrystal Pharma | $1.48 | 710.81% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | COCP | Buy Now | Cocrystal Pharma | $1.48 | 710.81% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2023 | COCP | Buy Now | Cocrystal Pharma | $1.48 | 710.81% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2023 | COCP | Buy Now | Cocrystal Pharma | $1.48 | 710.81% | HC Wainwright & Co. | Raghuram Selvaraju | $35 → $12 | Maintains | Buy | Get Alert |
| 01/24/2023 | COCP | Buy Now | Cocrystal Pharma | $1.48 | 2264.86% | HC Wainwright & Co. | Raghuram Selvaraju | $42 → $35 | Maintains | Buy | Get Alert |
| 11/07/2022 | COCP | Buy Now | Cocrystal Pharma | $1.48 | 2737.84% | HC Wainwright & Co. | Raghuram Selvaraju | $4 → $42 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Cocrystal Pharma (COCP)?
The latest price target for Cocrystal Pharma (NASDAQ: COCP) was reported by HC Wainwright & Co. on April 4, 2024. The analyst firm set a price target for $10.00 expecting COCP to rise to within 12 months (a possible 575.68% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cocrystal Pharma (COCP)?
The latest analyst rating for Cocrystal Pharma (NASDAQ: COCP) was provided by HC Wainwright & Co., and Cocrystal Pharma reiterated their buy rating.
When was the last upgrade for Cocrystal Pharma (COCP)?
There is no last upgrade for Cocrystal Pharma.
When was the last downgrade for Cocrystal Pharma (COCP)?
There is no last downgrade for Cocrystal Pharma.
When is the next analyst rating going to be posted or updated for Cocrystal Pharma (COCP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cocrystal Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cocrystal Pharma was filed on April 4, 2024 so you should expect the next rating to be made available sometime around April 4, 2025.
Is the Analyst Rating Cocrystal Pharma (COCP) correct?
While ratings are subjective and will change, the latest Cocrystal Pharma (COCP) rating was a reiterated with a price target of $0.00 to $10.00. The current price Cocrystal Pharma (COCP) is trading at is $1.48, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.